论文部分内容阅读
由于近年来新的化疗药物和治疗方案的改进,使非淋巴网细胞淋巴瘤(Non-Hodgkins Lymphoma,简称N-HL)的预后已显著改善,现将最近的治疗进展简述于下: 在开始治疗之前应先根据病变部位是局限或扩散而将其分期,关于这一点已有介绍;但有必要补充说明,因为某些方面N-HL的病程和淋巴网细胞瘤不同。淋巴网细胞瘤表现为颈,腋及腹股沟淋巴结病变者占80％;而
Due to improvements in new chemotherapeutic drugs and treatment regimens in recent years, the prognosis of Non-Hodgkins Lymphoma (N-HL) has been significantly improved. The most recent treatment advances are summarized below: At the beginning The treatment should be based on the location of the lesion is limited or spread and staging it, on this point have been introduced; but there is a need to add that some aspects of the course of N-HL and lymphoblastoma different. Lymphocytoma showed neck, axillary and inguinal lymph node lesions accounted for 80% ;.